FAQs

FAQ

All the answers to your Michigan Opioid Collaborative questions!

The Michigan Opioid Collaborative serves and supports the ENTIRE state of Michigan. We are here to help support any providers in Michigan with a desire to provide MOUD/MAT.

Not necessarily. Some patients have been in treatment at OTPs and they need ongoing support, but no longer require the level of treatment that an OTP specializes in providing. Some also need to work full-time of live at a difficult distance from available OTPs and cannot go daily. Providing MOUD/MAT to patients in an office setting can help a patient to seek treatment in a confidential and safe way while still being able to manage other responsibilities. 

Also, burprenorphine and other medications used in MOUD/MAT are safe to use when prescribed properly with the right monitoring. MOC is here to help you so that you can feel confident prescribing while you have Peer Mentoring from our Psychiatrists/Physicians who specialize in treating addictions using MOUD/MAT. 

You can receive Peer Mentoring from University of Michigan addiction specialists to help you treat patients with Opioid Use Disorders (OUDs) using Medication for Opioid Use Disorder/Medication Assisted Treatment (MOUD/MAT). 

We have Behavioral Health Consultants (BHCs) who are community-based and can provide direct patient support and referrals, as well as phone referrals to clinic staff for patients needing OUD treatment, other community resources, and referral information.

In order to provide MOUD/MAT, you will need a DATA Waiver from the DEA. This can be done by taking some additional classes and then by applying for the waiver. Our team is happy to help you with this process.

Once you have the DATA Waiver, the University of Michigan addiction specialists are here to help you as you begin providing MOUD/MAT. We are just a call away

Yes! Some providers choose to only use MOUD/MAT with patients in their existing panel. If every eligible prescriber treated only their current patients in need of MOUD/MAT, the gap between treatment need and capacity in the U.S. could be substantially narrowed.

If you are a healthcare professional in Michigan using methadone, buprenorphine, or naltrexone to treat OUDs, please feel free to contact us. We are building a network of support for MOUD/MAT providers. We can also assist you in identifying additional resources for your patients, provide Peer Mentoring, and support when you encounter a new clinical challenge.

Shoot us an email at moc-administration@umich.edu

The Michigan Opioid Collaborative is FREE to all participants for the MAT Psychiatrist/Physician consultation and Behavioral Health Consultant support.